Introduction
– Mitobulin is a prescription medication that contains the active ingredient Eribulin Mesylate.
– It is available under the brand name Mitobulin.
– This medication is primarily used for the treatment of certain types of advanced breast cancer.
Uses
– Mitobulin is prescribed for the treatment of metastatic breast cancer that has spread to other parts of the body.
– It is specifically indicated for patients who have previously received at least two types of chemotherapy for their breast cancer.
– This medication helps to slow down the growth and spread of cancer cells.
Dosage and Administration
– The dosage of Mitobulin is determined by the healthcare professional based on the patient’s body surface area.
– It is administered as an intravenous infusion over a specific period of time.
– The recommended dose and infusion duration will be determined by your healthcare provider.
Mechanism of Action
– Mitobulin belongs to a class of medications called microtubule inhibitors.
– It works by interfering with the microtubule structures in cancer cells, which are essential for their growth and division.
– By disrupting these structures, Mitobulin inhibits the growth of cancer cells and ultimately helps to slow down the progression of the disease.
Side Effects
– Common side effects of Mitobulin may include fatigue, nausea, vomiting, constipation, and hair loss.
– Serious side effects may include a decrease in white blood cell count, which can increase the risk of infections, as well as a decrease in platelet count, which can increase the risk of bleeding.
– If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Drug Interactions
– Mitobulin may interact with certain medications, including strong inhibitors or inducers of CYP3A4, which is an enzyme involved in the metabolism of many drugs.
– inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter, and herbal products, to avoid any potential drug interactions.
Precautions
– Before starting Mitobulin, inform your healthcare provider about any medical conditions you have, especially liver or kidney problems.
– This medication may not be suitable for individuals with certain heart conditions or a history of QT prolongation.
– avoid pregnancy while using Mitobulin, as it may cause harm to the unborn baby.
Storage
– Mitobulin should be stored in its original packaging at room temperature, away from excessive heat and moisture.
– Keep it out of reach of children and pets.
– Do not use the medication if it has passed the expiration date.
Patient Tips
– Follow the dosage instructions provided by your healthcare provider and do not change the dose or schedule without consulting them.
– Stay hydrated and maintain a healthy diet during treatment to manage potential side effects.
– Report any unusual symptoms or side effects to your healthcare provider promptly.
– Keep all scheduled appointments for monitoring and blood tests.
– If you have any questions or concerns about Mitobulin, don’t hesitate to reach out to your healthcare provider for further guidance.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Eribulin (Drugs.com) [Accessed 13 Jun. 2024] (online) Available at:
- Drugs Approved for Soft Tissue Sarcoma (National Cancer Institute) [Accessed 16 Jun. 2024] (online) Available at:
- Jain S, Vahdat LT. Eribulin mesylate. Clin Cancer Res. 2011 Nov 1;17(21):6615-22. doi: 10.1158/1078-0432.CCR-11-1807. Epub 2011 Aug 22. [Accessed 24 Jun. 2024] Available at:
- A to Z List of Cancer Drugs (National Cancer Institute) [Accessed 20 Jun. 2024] (online) Available at:
Reviews
There are no reviews yet.